CDNA

CareDx, Inc.
Data: 2026-09-11
Analyzing positioning… Options positioning — based on yesterday's biggest open-interest changes See the chart Institutional flows
Track record
signal day → next-day price move
Quick Stats
Sep 11, 2026

36.5

AI Score

SELL

0.53

Volume Ratio

Nov 03, 2026

Next Earnings

19

+ve Days (30d)

11

-ve Days (30d)

CDNA Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

CDNA Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

CDNA Options - Sort by Max open Interest (near term)

11th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CDNA Daily Out of Money Options - Sort by Max open Interest (near term)

11th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CDNA Daily In the Money Options - Sort by Max open Interest (near term)

11th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CDNA Most Active Options by Volume(near term)

11th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track
CDNA Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select an indicator above — it will be added as a pane under the price chart with aligned dates.

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

CDNA Stock Summary

Last updated Sep 11, 2026

CDNA is currently trading at $50.26, positioned above its 200-day moving average of $25.74, indicating a long-term uptrend. The stock has a 52-week range of $13.23 to $53.6712.

Technical Analysis: The 50-day moving average stands at $42.41, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 63.11, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.139, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates CDNA at 36.5/100 with a SELL recommendation.

CDNA (CareDx, Inc.) Indicators

Last updated Sep 11, 2026

Indicator Value
RSI(14) 63.11
CMF (20) 0.139
ROC (10) -3.552
ADX (14) 42.633
Indicator Value
MACD (12,26,9) 2.193
AROONOSC (14) 28.571
WILLAMS %R (14) -45.411
MFI (14) 64.731

CDNA Candlestick Patterns

Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.

Date Pattern Signal 5-Day Hit Rate Edge vs Baseline Sample
Sep 09 Gravestone Doji Bullish 55.2% +2.2 pts 21200
Sep 09 Inverted Hammer Bullish 56.4% +3.4 pts 19834
Aug 31 Thrusting Line Bearish 50.0% +3.0 pts 9556

These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.

CareDx, Inc. is above both the 50 Day and 200 Day SMA which is considered Bullish.

CDNA Moving Averages Analysis

CareDx, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Sep 11, 2026

CareDx, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Sep 11, 2026

CDNA (CareDx, Inc.) Simple Moving Averages

Moving Averages are last updated Sep 11, 2026

Days MA
10 49.98
20 49.07
30 48.2
50 42.41
100 32.6
200 25.74

CDNA Fundamental Analysis

P/E (Forward) 144.9275
P/E (Trailing) 24.1691
Market Cap ($) 2.6 billion
Earnings/Share ($) 2.07
Net Profit Margin (%) 0.2423
Dividend/Share ($) --
EPS Estimate Current Year ($) 1.2043
EPS Estimate Next Year ($) 1.3286
WallStreet Target Price ($) 54.14
Most Recent Quarter

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.